Skip to content
Menu
About CLTI
Technology
Products
Clinical Evidence
PROMISE I Study Results
ALPS Post-Market Study
First-in-Human Study Results
Publications
Patients
Company
Clinical Advisors
News
Media
Articles
Contact
United States
Publications
Cost-Effectiveness of Percutaneous Deep Vein Arterialization for Patients With No-Option Chronic Limb-Threatening Ischemia: An Exploratory Analysis Based on the PROMISE I Study
Journal of Critical Limb Ischemia
December 2021
Early and Eighteen Month Clinical Outcomes of First UK Case of Percutaneous Deep Vein Arterialisation (pDVA) to Treat “No Option” Chronic Limb-Threatening Ischemia Using the LimFlow System
CVIR Endovascular
August 2021
PROMISE I: Early Feasibility Study of the LimFlow System for Percutaneous Deep Vein Arterialization in No-Option Chronic Limb-Threatening Ischemia: 12-Month Results
Journal of Vascular Surgery
May 2021
Midterm Outcomes of Percutaneous Deep Venous Arterialization With a Dedicated System for Patients With No-Option Chronic Limb-Threatening Ischemia: The ALPS Multicenter Study
Journal of Endovascular Therapy
May 2020
PROMISE International; A Clinical Post Marketing Trial Investigating the Percutaneous Deep Vein Arterialization (LimFlow) in the Treatment of No-Option Chronic Limb Ischemia Patient
CVIR Endovascular
December 2019
Interim Results of the PROMISE I Trial to Investigate the LimFlow System of Percutaneous Deep Vein Arterialization for the Treatment of Critical Limb Ischemia
The Journal of Invasive Cardiology
March 2019
Percutaneous Deep Venous Arterialization in Patients With Critical Limb Ischemia
The Journal of Cardiovascular Surgery
May 2018
